Cardiovascular diseases (CVDs) are associated with high mortality rate all over the world. Strokes and heart attacks are two major types of CVD contributing to the growing mortality rate globally. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease (CHD) is the most common type of CVD resulting in heart attack in the US. In the US, about 370,000 people die due to CHD every year. The EP diagnostics and treatment devices such as ablation catheters, pacemakers, and implantable cardioverter defibrillators (ICDs) are used extensively for the CVD treatment.
Technavio’s analysts forecast the global electrophysiology devices market to grow at a CAGR of 7.91% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the global electrophysiology devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of electrophysiology devices.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Technavio's report, Global Electrophysiology Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Boston Scientific - GE Healthcare - Medtronic - Philips Healthcare - St. Jude Medical
Other prominent vendors - Siemens Healthcare - LivaNova - AngioDynamics - Atrium Medical - Biosense Webster - Cook Group - Edward Lifesciences - Innovative Cardiovascular Solutions - Transverse Medical - Cardiac Science - MicroPortScientific - Welch Allyn - Vimecon - Suzuken - Spacelabs Healthcare - Cardiac Science - Imricor Medical Systems - Advanced Cardiac Therapeutics - BIOTRONIK
Market driver - Increasing incidence of arrhythmia cases - For a full, detailed list, view our report
Market challenge - Complications associated with ablation procedures - For a full, detailed list, view our report
Market trend - Use of mobile ECG monitoring systems - For a full, detailed list, view our report
Key questions answered in this report - What will the market size be in 2020 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Methodology Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
Our reports have been used by over 10K customers, including:
275 pages •
By Global Industry Analysts
• May 2020
Amid the COVID-19 crisis and the looming economic recession, the Taste Modulators market worldwide will grow by a projected US$930.6 Million, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 8.8%. Sweet Modulators, one of the segments analyzed and sized in this study, is forecast to grow at over 9.3%...
Get an in-depth analysis of COVID-19 impact on global cardiac prosthetic devices market. The cardiac prosthetic devices market is expected to grow at a CAGR of over 14% during the period 2019–2025. The global cardiac prosthetic devices market is expected to grow at a significant rate during the forecast period. The growing incidence...
Chronic Heart Failure Global Clinical Trials Review, H1, 2020 Summary Clinical trial report, “Chronic Heart Failure Global Clinical Trials Review, H1, 2020" provides an overview of Chronic Heart Failure Clinical trials scenario.This report provides top line data relating to the clinical trials on...
192 pages •
By Global Industry Analysts
• Jun 2020
Amid the COVID-19 crisis and the looming economic recession, the POC Lipid Testing market worldwide will grow by a projected US$53.3 Million, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 2.9%. Hyperlipidemia, one of the segments analyzed and sized in this study, is forecast to grow at over 2.7% and...
Cholesteryl Ester Transfer Protein - Pipeline Review, H1 2020 Summary According to the recently published report ’Cholesteryl Ester Transfer Protein - Pipeline Review, H1 2020’; Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) pipeline Target constitutes close to 6 molecules....
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.